Electromed Inc (ELMD)
Official siteHEALTHCARE • MEDICAL DEVICES • AMEX
Market Cap: $198.79M
Last updated: Nov 17, 2026 at 11:04 AM ET
Electromed Inc (ELMD) Earnings: Report Dates and Results
Electromed (ELMD) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Electromed reported EPS of $0.32, above the $0.26 estimate. It beat the EPS estimate in each of the last 12 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ELMD has an expected report date of Feb 8, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 21.9% above the $0.32 reported for the quarter ended Dec 31, 2025.
ELMD Earnings Call
The latest ELMD earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 34 quarters below that had an estimate, ELMD beat 24, missed 9 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $18.68M, up 10.6% from $16.89M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.32 | $0.26 | $0.22 - $0.29 | +23.08% | Beat | +28.0% | 2 | 0 up, 1 down | Nov 10, 2026 | $18.68M |
| Jun 30, 2026 | $0.39 | $0.32 | $0.30 - $0.33 | +21.88% | Beat | +56.0% | 3 | 3 up, 0 down | Aug 25, 2026 | $19.42M |
| Mar 31, 2026 | $0.35 | $0.24 | $0.24 - $0.26 | +46.23% | Beat | +65.4% | 3 | 1 up, 1 down | May 12, 2026 | $18.57M |
| Dec 31, 2025 | $0.32 | $0.26 | $0.24 - $0.28 | +23.08% | Beat | +45.5% | 4 | 2 up, 2 down | Feb 10, 2026 | $18.90M |
| Sep 30, 2025 | $0.25 | $0.21 | $0.19 - $0.23 | +19.05% | Beat | +56.3% | 4 | 1 up, 1 down | Nov 12, 2025 | $16.89M |
| Jun 30, 2025 | $0.25 | $0.22 | $0.21 - $0.22 | +13.64% | Beat | +25.0% | 2 | 0 up, 2 down | Aug 26, 2025 | $17.39M |
| Mar 31, 2025 | $0.21 | $0.20 | N/A | +5.00% | Beat | +23.5% | N/A | 0 up, 0 down | May 13, 2025 | $15.68M |
| Dec 31, 2024 | $0.22 | $0.18 | N/A | +22.22% | Beat | +15.8% | N/A | 0 up, 0 down | Feb 11, 2025 | $16.25M |
| Sep 30, 2024 | $0.16 | $0.03 | $0.03 - $0.03 | +433.33% | Beat | +700.0% | 1 | 0 up, 0 down | Nov 12, 2024 | $14.67M |
| Jun 30, 2024 | $0.20 | $0.14 | N/A | +42.86% | Beat | +66.7% | N/A | 0 up, 0 down | Aug 27, 2024 | $14.83M |
| Mar 31, 2024 | $0.17 | $0.13 | $0.13 - $0.13 | +30.77% | Beat | +41.7% | 1 | 0 up, 0 down | May 7, 2024 | $13.87M |
| Dec 31, 2023 | $0.19 | $0.10 | $0.10 - $0.10 | +90.00% | Beat | +72.7% | 1 | 0 up, 0 down | Feb 13, 2024 | $13.69M |
| Sep 30, 2023 | $0.02 | $0.10 | $0.10 - $0.10 | -80.00% | Miss | +100.0% | 1 | 0 up, 0 down | Nov 7, 2023 | $12.32M |
| Jun 30, 2023 | $0.12 | $0.13 | N/A | -7.69% | Miss | +200.0% | N/A | 0 up, 0 down | Aug 22, 2023 | $13.61M |
| Mar 31, 2023 | $0.12 | $0.10 | $0.10 - $0.10 | +20.00% | Beat | +71.4% | 1 | 0 up, 0 down | May 9, 2023 | $12.07M |
| Dec 31, 2022 | $0.11 | $0.02 | $0.01 - $0.06 | +450.00% | Beat | +10.0% | 2 | 0 up, 0 down | Feb 14, 2023 | $11.73M |
| Sep 30, 2022 | $0.01 | $0.04 | $0.03 - $0.04 | -75.00% | Miss | -80.0% | 2 | 0 up, 0 down | Nov 8, 2022 | $10.66M |
| Jun 30, 2022 | $0.04 | $0.08 | $0.08 - $0.08 | -50.00% | Miss | 0.0% | 1 | 0 up, 0 down | Aug 23, 2022 | $11.27M |
| Mar 31, 2022 | $0.07 | $0.05 | N/A | +40.00% | Beat | +133.3% | N/A | 0 up, 0 down | May 10, 2022 | $10.14M |
| Dec 31, 2021 | $0.10 | $0.07 | $0.07 - $0.07 | +42.86% | Beat | -23.1% | 1 | 0 up, 0 down | Feb 8, 2022 | $10.25M |
| Sep 30, 2021 | $0.05 | $0.06 | $0.02 - $0.10 | -16.67% | Miss | -16.7% | 2 | 1 up, 0 down | Nov 9, 2021 | $10.00M |
| Jun 30, 2021 | $0.04 | $0.06 | $0.05 - $0.06 | -33.33% | Miss | -71.4% | 2 | N/A | Aug 24, 2021 | $9.47M |
| Mar 31, 2021 | $0.03 | $0.06 | N/A | -50.00% | Miss | -57.1% | N/A | N/A | May 11, 2021 | $8.79M |
| Dec 31, 2020 | $0.13 | $0.04 | $0.01 - $0.07 | +225.00% | Beat | -7.1% | 2 | N/A | Feb 9, 2021 | $9.50M |
| Sep 30, 2020 | $0.06 | -$0.05 | -$0.05 - -$0.05 | +220.00% | Beat | -50.0% | 1 | N/A | Nov 10, 2020 | $8.00M |
| Jun 30, 2020 | $0.14 | -$0.15 | -$0.15 - -$0.15 | +193.33% | Beat | +7.7% | 1 | N/A | Aug 25, 2020 | $6.88M |
| Mar 31, 2020 | $0.07 | $0.06 | N/A | +16.67% | Beat | +75.0% | N/A | N/A | May 12, 2020 | $8.74M |
| Dec 31, 2019 | $0.14 | $0.04 | $0.04 - $0.04 | +250.00% | Beat | +250.0% | 1 | N/A | Feb 11, 2020 | $8.55M |
| Sep 30, 2019 | $0.12 | $0.01 | $0.01 - $0.01 | N/A | N/A | +500.0% | 1 | N/A | Nov 12, 2019 | $8.30M |
| Jun 30, 2019 | $0.13 | $0.13 | N/A | 0.00% | In line | 0.0% | N/A | N/A | Aug 27, 2019 | $8.60M |
| Mar 31, 2019 | $0.04 | N/A | N/A | N/A | N/A | 0.0% | N/A | N/A | May 7, 2019 | $7.41M |
| Dec 31, 2018 | $0.04 | N/A | N/A | N/A | N/A | -31.6% | N/A | N/A | Feb 12, 2019 | $8.01M |
| Sep 30, 2018 | $0.02 | N/A | N/A | N/A | N/A | +100.0% | N/A | N/A | Nov 13, 2018 | $7.28M |
| Jun 30, 2018 | $0.13 | $0.07 | N/A | +85.71% | Beat | +18.2% | N/A | N/A | Sep 25, 2018 | $7.87M |
| Mar 31, 2018 | $0.04 | $0.07 | N/A | -42.86% | Miss | -50.0% | N/A | N/A | May 8, 2018 | $7.17M |
| Dec 31, 2017 | $0.06 | $0.03 | N/A | +95.00% | Beat | +17.0% | N/A | N/A | Feb 13, 2018 | $6.96M |
| Sep 30, 2017 | $0.01 | $0.03 | N/A | -66.67% | Miss | -50.0% | N/A | N/A | Nov 7, 2017 | $6.30M |
| Jun 30, 2017 | $0.11 | N/A | N/A | N/A | N/A | +175.0% | N/A | N/A | Sep 5, 2017 | $7.27M |
| Mar 31, 2017 | $0.08 | N/A | N/A | N/A | N/A | +33.3% | N/A | N/A | May 15, 2017 | $6.67M |
| Dec 31, 2016 | $0.05 | $0.03 | N/A | +66.67% | Beat | -50.0% | N/A | N/A | Feb 7, 2017 | $6.37M |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was $1.31, up 55.6% from the year before. It was $0.26 for the year ended Jun 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | $1.31 | +55.6% |
| Jun 30, 2025 | $0.84 | +44.8% |
| Jun 30, 2024 | $0.58 | +61.1% |
| Jun 30, 2023 | $0.36 | +38.5% |
| Jun 30, 2022 | $0.26 | N/A |
| Jun 30, 2021 | $0.26 | -44.7% |
| Jun 30, 2020 | $0.47 | +104.3% |
| Jun 30, 2019 | $0.23 | N/A |
| Jun 30, 2018 | $0.24 | N/A |
| Jun 30, 2017 | $0.26 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,200 words across 6 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 3,158 | 6 | |
| 2026Q2 | Jun 30, 2026 | 3,891 | 6 | |
| 2026Q1 | Mar 31, 2026 | 4,072 | 6 | |
| 2025Q4 | Dec 31, 2025 | 4,815 | 7 | |
| 2025Q3 | Sep 30, 2025 | 3,062 | 6 | |
| 2025Q2 | Jun 30, 2025 | 2,551 | 5 | |
| 2025Q1 | Mar 31, 2025 | 4,005 | 5 | |
| 2024Q4 | Dec 31, 2024 | 3,399 | 5 |
2026Q3 Earnings Call
Opening remarks
Mike Cavanaugh Investor Relations Good afternoon, and thank you for joining the Electromed earnings call. Earlier today, Electromed Inc. released financial results for the third quarter of fiscal 2026. The press release is currently available on the company's website at www.smartvest.com. Before we get started, I would like to remind everyone that some of the statements that management will make on this call are considered forward-looking statements, including statements about the company's future operating and financial results and plans. Such statements are subject to risks and uncertainties that could cause actual performance or achievements to be materially different from those projected. Any such statements represent management's expectations as of today's date. You should not place any undue reliance on those forward-looking statements and the company does not undertake any obligation to update or revise forward-looking statements, whether as a result of new information, future events or otherwise. Please refer to the company's SEC filings for further guidance on this matter. Joining me on the call today are Jim Cunniff, Electromed's President and Chief Executive Officer; and Brad Nagel, Chief Financial Officer. As on previous calls, Jim will provide operational highlights from the quarter. Brad will then review the financials and we will close with a question-and-answer session. With that, I will now turn the call over to Jim Cunniff, President and Chief Executive Officer of Electromed.
James Cunniff President and Chief Executive Officer Good afternoon, everyone, and thank you for joining us today. I'm excited to share our third quarter results. Let me start with the headlines. Q3 marks our 14th consecutive quarter of year-over-year revenue and profit growth. We delivered revenue of $18.6 million, representing 18.4% growth compared to the prior year. This performance reflects the strength of our commercial execution and the growing recognition of SmartVest as the leading solution for Airway Clearance. Growth was broad-based across our business. Our flagship Home Care segment grew a robust 19%. Our distributor revenues increased 3% driven by consistent demand from our DME partners. Hospital grew 43% over prior year and rebounded after a slow second quarter. This diversified growth demonstrates the strength of our market position and the effectiveness of our multichannel strategy. Even more impressive is our record bottom line performance. Operating income increased to $3.8 million in the third quarter, a 76% increase versus prior year. Diluted earnings per share came in at $0.35, up 67% versus the prior year. From a balance sheet perspective, we maintained a strong cash position of $17 million. As you may recall, our Board approved a $10 million stock repurchase authorization in the first quarter, reflecting our confidence that Electromed represents a sound investment; yet we slowed repurchasing activity in Q3 as we assess the recent macro market dynamics.
Frequently Asked Questions About ELMD
When is Electromed's next earnings date?
Electromed's next earnings report is expected for Feb 8, 2027.
Did ELMD beat earnings estimates last quarter?
Yes. Electromed reported EPS of $0.32 for the quarter ended Sep 30, 2026, above the $0.26 estimate, a 23.08% surprise.
What EPS do analysts expect from ELMD next quarter?
The consensus EPS estimate for Electromed for the quarter ending Dec 31, 2026 is $0.39 from 2 analysts, with estimates from $0.36 to $0.41.
How often does ELMD beat earnings estimates?
Electromed beat the EPS estimate in each of the last 12 quarters, with an average surprise of +64.26%.
ELMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors